Both in Pharmaceuticals
Climb Bio vs Faeth Therapeutics
Over the past year CLYM returned −31.1% and FTH returned −49.8%; their daily moves had a correlation of 0.57.
CLYM −31.1% FTH −49.8%Growth of $1, one year, split-adjusted
| Metric | CLYM | FTH |
|---|---|---|
| Price | $9.82 | $18.80 |
| Market cap | $564.0M | $485.8M |
| Today | −9.99% | −8.74% |
| 1 month | −30.2% | −46.5% |
| 6 months | +7.2% | — |
| Year to date | +145.5% | — |
| 1 year | +406.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $183.1M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 73.6% | — |
| Short % of float | 25.4% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).